Press & Media

Euroclone Signs Distribution Agreements with PlexBio for the IntelliPlex™ Instrument System and Reagents


Taipei, Taiwan- May 8, 2018 - PlexBio Co., Ltd, an emerging multi-national diagnostic company, has signed an agreement with Euroclone S.p.A. of Milan to be the exclusive distributor its IntelliPlex™ 1000 πCode Processor and PlexBio™ 100 Fluorescent Analyzer for use in the Italian life science research market. The agreement also provides for the sale of research reagents based on PlexBio’s πCode™ MicroDisc technology and accessories by Euroclone’s marketing and sales teams in Italy. In a parallel agreement, PlexBio and Euroclone Diagnostica Srl of Siziano have signed an exclusive distribution contract for the marketing and sale of PlexBio’s IntelliPlex™ 1000 πCode Processor, the PlexBio™ 100 Fluorescent Analyzer and several of PlexBio’s CE-Marked IVD kits for molecular diagnostics in a targeted segment of the Italian IVD clinical market. The agreements provide PlexBio a direct sales and support channel in Italy with a nationally-recognized and highly-respected partner company.

PlexBio Chief Operating Officer Dr. Stuart M. Palmer said, “Establishing these distribution relations with Euroclone is a critical first step to PlexBio’s European market entry strategy and we are very happy that, together with our partners at Euroclone, we will be able to provide an innovative and powerful workflow solution for two key multiplex testing market segments in Italy. The foundation of our relationship is that both of our companies are fully committed to seeing customers accelerate their research or diagnostic testing with highly efficient and cost-effective tools”.

PlexBio’s πCode™ MicroDisc technology is currently the largest multiplexing platform commercially available, capable of generating over 16,000 circular image patterns. Each image pattern corresponds to an individual target which can be detected simultaneously via the advanced optical imaging and fluorescence reading capabilities of the PlexBio™ 100. By using this higher order multiplexing platform, PlexBio is able to offer highly sensitive and specific results for both immuno and molecular assay formats from very low input sample volumes – saving time and labor. The PlexBio™ 100 analyzer works in conjunction with the IntelliPlex™ 1000 processor for target hybridization, πCode™ MicroDisc washing and fluorescence labelling.

About Euroclone S.p.A.: The company was established in the 1990’s with the goal of focusing on the development of OEM agreements of innovative products for sale into the Biotechnology, Medical and Diagnostic fields. This early success led to the merger of Euroclone and its sister company CELBIO in 2009. Euroclone S.p.A. is the parent company of Euroclone Diagnostica, Srl. The integrated company continues its longstanding tradition of customer care while evolving now to a major supplier of up-to-date and own-branded products. https://www.euroclonegroup.it/

About PlexBio Co., Ltd.: The company established in May 2010, designs, develops and manufactures IVD products and instrumentation from its headquarters in Taipei, Taiwan and its affiliate location in Jiangsu Province, China. PlexBio has also established an Innovative Technology Center in South San Francisco, CA, USA. The company is a listed company on the Taiwan emerging stock market. http://www.plexbio.com


Contact Information:
PlexBio, Co., Ltd.
Address: 6F-1, No. 351, Yangguang St., Neihu District, Taipei City 11491, Taiwan
Tel: +886-2-2627-5878
Fax: +886-2-2627-5979
E-mail: contact@plexbio.com